Ascendis Pharma A/S
ASND
View Detailed Chart
221.408USD
+0.508+0.23%
Market hours （ET）Quotes delayed by 15 min
5.08BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.23%
5 Days
-1.08%
1 Month
-3.31%
6 Months
+15.32%
Year to Date
+3.83%
1 Year
+39.88%
View Detailed Chart
TradingKey Stock Score of Ascendis Pharma A/S
Currency: USD Updated: 2026-03-26Key Insights
Ascendis Pharma A/S's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 391 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 293.67.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Ascendis Pharma A/S's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Ascendis Pharma A/S Highlights
StrengthsRisks
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 110.04% year-on-year.
Undervalued
The company’s latest PE is -68.86, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 68.62M shares, increasing 0.00% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 690.00 shares of this stock.
Analyst Rating
Based on
18
analysts
Strong Buy
Current Rating
293.670
Target Price
+36.25%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Ascendis Pharma A/S News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Ascendis Pharma A/S Info
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ticker SymbolASND
CompanyAscendis Pharma A/S
CEOMoller Mikkelsen (Jan)
Websitehttps://ascendispharma.dk/
Related Instruments
-2.66%
-1.04%
+0.87%
+1.84%
+1.53%
+0.59%
-0.71%
-0.12%
-0.39%
-0.72%
-0.41%
+1.62%
-0.16%
+0.47%
-1.94%
0.00%
+0.17%
-2.19%
-1.68%
-0.85%Popular Symbols
252.440
-0.450 (-0.18%)
168.955
-2.285 (-1.33%)
66330.880
-2644.330 (-3.83%)
275.165
+1.815 (+0.66%)
1998.440
-63.950 (-3.10%)
365.760
-6.350 (-1.71%)
4532.480
+152.420 (+3.48%)
96.999
+3.677 (+3.94%)
1.154
+0.001 (+0.11%)
159.777
-0.010 (-0.01%)
